Our remarkable journey with a US-based Independent Diagnostic Testing Facility (IDTF) is a testament to overcoming obstacles and achieving amazing outcomes.
Techindia was contacted by a leading US-based IDTF that was facing critical issues with their cardiac interpretation software and their previous partnership. Despite having a growing patient base, their tool was plagued by a staggering 90% false positive rate. This was significantly affecting the accuracy of diagnoses and the quality of patient care.
Techindia faced a formidable challenge. With no established protocols or project documentation in place, they embarked on uncharted territory. Managing the overwhelming volume of ten thousand devices, encompassing two million events and Holters, demanded a meticulous approach.
Undeterred by the magnitude of the task, Techindia assembled a team of 150 FTE and 20 cross-tower staff members. Guided by an agile incubation team, they launched into a rigorous testing phase to pinpoint root causes and devise targeted solutions.
The testing phase uncovered many issues, from tool functionality to workflow inefficiencies. From sluggish performance to documentation disparities, each hurdle was methodically documented and prioritized.
Techindia adopted a systematic and comprehensive approach. We tackled critical areas such as arrhythmia correction and anomaly separation through phased solutions. By segregating normal data from anomalies, they achieved a substantial 30% improvement in interpretation accuracy.
The client experienced a surge in business, with a 50% to 70% increase in the first year alone. This translated to annual savings of 8 – 15 million dollars, with a remarkable achievement of 100% Turnaround Time month after month. They also attained a 99% quality rating and an 80% reduction in false positives.
Previous